Lymphoma
A significant diffuse component is a predictor for lowered survival
Published in Blood Weekly, May 8th, 2003
According to published research from the United States, "Grade 3 follicular lymphoma, FL3, is thought to have an aggressive clinical course. On the basis of possible biologic differences, the new World Health Organization (WHO) classification of lymphoma suggests further subdivision of FL3 into grades 3a and 3b and states that the percentage of involvement by diffuse large B-cell lymphoma (DLBCL) should also be reported.
"However, the clinical implications of these features are unclear.
Therefore, we...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
Source: Blood Weekly (2003-05-08)
More Articles from Blood Weekly
- Stem Cell Transplantation
OX40 ligation prevents graft-versus-host disease - Transfusion Medicine
Monoclonal IgG may be IVIG alternative for immune thrombocytopenia - Leukemia
Vgamma1Vdelta1+ T cells can lyse tumor cells - Non-Hodgkin Lymphoma
Some prescription medications reduce risk in women - Stem Cell Research
Different PECAM-1 isoforms regulate fundamental elements of hematopoiesis - Stem Cell Transplantation
Automated progenitor cell count assay can improve yield - More from this issue of Blood Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
